Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Glenmark Sets Sights On Regional Out-Licensing, Lot Riding On US Rhinitis NDA
May 31 2018
•
By
Anju Ghangurde
GLENMARK IS KEEN TO MONETIZE SOME OF ITS KEY R&D ASSETS VIA LICENSING
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip